Safety, Tolerability, and Antiviral Activity of ANA598 in Patients With Genotype-1 Chronic HCV Infection
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the safety, tolerability, and antiviral activity
of ANA598 in patients with genotype-1 chronic hepatitis C infection.